CoChat

Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D

Open access

Published version of a preprint

The DOI matches its Crossref record; 98 of the 99 references it cites were found in a registry or an index.

Abstract

Most signals detected by genome-wide association studies map to non-coding sequence and their tissue-specific effects influence transcriptional regulation. However, key tissues and cell-types required for functional inference are absent from large-scale resources. Here we explore the relationship between genetic variants influencing predisposition to type 2 diabetes (T2D) and related glycemic traits, and human pancreatic islet transcription using data from 420 donors. We find: (a) 7741 cis -eQTLs in islets with a replication rate across 44 GTEx tissues between 40% and 73%; (b) marked overlap between islet cis- eQTL signals and active regulatory sequences in islets, with reduced eQTL effect size observed in the stretch enhancers most strongly implicated in GWAS signal location; (c) enrichment of islet cis- eQTL signals with T2D risk variants identified in genome-wide association studies; and (d) colocalization between 47 islet cis- eQTLs and variants influencing T2D or glycemic traits, including DGKB and TCF7L2 . Our findings illustrate the advantages of performing functional and regulatory studies in disease relevant tissues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-18581-8

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Islet eQTLs and their activity in other tissues. a Proportion of islet eQTLs active in GTEx tissues using p-value enrichment analysis (π1 estimate for replication). b Comparison between eQTLs discovered in islets and their p-values in β-cells (top figure, N = 26) and whole pancreas tissue from GTEX (bottom figure, n = 149). The axes show the −log10 p-value of the eQTL associations adjusted by the eQTL direction (positive or negative) of effect with respect to the reference allele. Source data are provided as a Source data file.
Fig. 1 Islet eQTLs and their activity in other tissues. a Proportion of islet eQTLs active in GTEx tissues using p-value enrichment analysis (π1 estimate for replication). b Comparison between eQTLs discovered in islets and their p-values in β-cells (top figure, N = 26) and whole pancreas tissue from GTEX (bottom figure, n = 149). The axes show the −log10 p-value of the eQTL associations adjusted by the eQTL direction (positive or negative) of effect with respect to the reference allele. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 2 Integration of islet eQTL with epigenomic information. a Distribution of absolute effect sizes for islet eQTLs in each islet chromatin state. b Distribution of absolute effect sizes for islet eQTL in ATAC-seq peaks in three islet chromatin states. eQTL SNPs in ATAC-seq peaks in stretch enhancers have significantly lower effect sizes than SNPs in ATAC-seq peaks in active TSS and typical enhancer states. P-values were obtained from a Wilcoxon rank-sum test. c Fold enrichment for transcription factor footprint motifs to overlap low vs high effect size islet eQTL SNPs. d TF footprint motif directionality fraction vs fold enrichment for the TF footprint motif to overlap islet eQTLs. TF footprint motif directionality fraction is calculated as the fraction of eQTL SNPs overlapping a TF footprint motif, where the base preferred in the motif is associated with increased expression of the eQTL eGene. Significance of skew of this fraction from a null expectation of 0.5 was calculated using the binomial test. Source data are provided as a Source data file.
Fig. 2 Integration of islet eQTL with epigenomic information. a Distribution of absolute effect sizes for islet eQTLs in each islet chromatin state. b Distribution of absolute effect sizes for islet eQTL in ATAC-seq peaks in three islet chromatin states. eQTL SNPs in ATAC-seq peaks in stretch enhancers have significantly lower effect sizes than SNPs in ATAC-seq peaks in active TSS and typical enhancer states. P-values were obtained from a Wilcoxon rank-sum test. c Fold enrichment for transcription factor footprint motifs to overlap low vs high effect size islet eQTL SNPs. d TF footprint motif directionality fraction vs fold enrichment for the TF footprint motif to overlap islet eQTLs. TF footprint motif directionality fraction is calculated as the fraction of eQTL SNPs overlapping a TF footprint motif, where the base preferred in the motif is associated with increased expression of the eQTL eGene. Significance of skew of this fraction from a null expectation of 0.5 was calculated using the binomial test. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 3 GWAS SNPs in islet eQTLs. a Enrichment of eQTL effect sizes in different GTEx tissues at T2D (all) and glycemic GWAS-associated variants. Numbers within square brackets denote the number of variants implicated for each the trait. Also shown a subset of T2D GWAS associated with reduced insulin secretion or islet β-cell dysfunction (T2D (BC)) and type 1 diabetes (T1D)-associated signals. b LocusCompare plot for the T2D GWAS p-values in the TCF7L2 locus. Plots on the right −log10 p-values for the GWAS (top) and for the the eQTL for TCF7L2, highlighting in both the GWAS lead SNP in the cis window tested for eQTLs. On the left it shows a comparison of the p-values in both analyses. Source data are provided as a Source data file.
Fig. 3 GWAS SNPs in islet eQTLs. a Enrichment of eQTL effect sizes in different GTEx tissues at T2D (all) and glycemic GWAS-associated variants. Numbers within square brackets denote the number of variants implicated for each the trait. Also shown a subset of T2D GWAS associated with reduced insulin secretion or islet β-cell dysfunction (T2D (BC)) and type 1 diabetes (T1D)-associated signals. b LocusCompare plot for the T2D GWAS p-values in the TCF7L2 locus. Plots on the right −log10 p-values for the GWAS (top) and for the the eQTL for TCF7L2, highlighting in both the GWAS lead SNP in the cis window tested for eQTLs. On the left it shows a comparison of the p-values in both analyses. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 4 Functional assessment of DGKB eQTL locus. a We show the two of the three independent islet eQTL signals that colocalize with identified independent GWAS variants near the DGKB gene locus (lead SNP rs17168486 referred at as the 5′ signal and lead SNP rs10231021 referred to as the 3′ signal). These signals colocalize with two independent T2D GWAS signals shown in b, where rs17168486 is referred to as the 5′ signal and lead SNP rs2191349 referred to as the 3′ signal. LD information was not available for SNPs denoted by (×). The third GWAS variant and the third eSNP are not shown as both are located outside this region and in opposite location with respect to DGKB, showing no evidence of colocalization. c Normalized DGKB gene expression levels relative to the T2D-risk-allele dosage at the 3′ islet eQTL for DGKB lead SNP rs10231021. eQTL p-value adjusted to the beta distribution is shown. d Genome browser view of the region highlighted in purple in a and b that contains the 3′ DGKB eQTL and T2D GWAS signals. Two regulatory elements (element 1 highlighted in green, element 2 highlighted in blue) overlapping ATAC-seq peaks in islet β-cells (islet single nuclei ATAC-seq49) and bulk islets (islet track represents one islet sample from Varshney et al.15) were cloned into a luciferase reporter assay construct for functional validation. All ATAC-seq tracks are normalized to 10 M reads and scaled from 0–15. e Log 2 luciferase assay activities (normalized to empty vector) are shown for in rat (832/13), mouse (MIN6), and human (EndoC-βH1) β-cell lines for the element 2 (cloned in the forward orientation), highlighted in blue in d. The risk haplotype shows significantly higher (p < 0.05) activity than the non-risk haplotype in 832/13 and MIN6, consistent with the eQTL direction shown in c. P-values were determined using unpaired two-sided t-tests. f EMSA for probes with risk and non-risk alleles at the four SNPs overlapping the regulatory element validated in e, using nuclear extract from MIN6 cells. Filled arrows, allele-specific binding; open arrows, non-allele-specific binding of proteins to probes. Source data are provided as a Source data file.
Fig. 4 Functional assessment of DGKB eQTL locus. a We show the two of the three independent islet eQTL signals that colocalize with identified independent GWAS variants near the DGKB gene locus (lead SNP rs17168486 referred at as the 5′ signal and lead SNP rs10231021 referred to as the 3′ signal). These signals colocalize with two independent T2D GWAS signals shown in b, where rs17168486 is referred to as the 5′ signal and lead SNP rs2191349 referred to as the 3′ signal. LD information was not available for SNPs denoted by (×). The third GWAS variant and the third eSNP are not shown as both are located outside this region and in opposite location with respect to DGKB, showing no evidence of colocalization. c Normalized DGKB gene expression levels relative to the T2D-risk-allele dosage at the 3′ islet eQTL for DGKB lead SNP rs10231021. eQTL p-value adjusted to the beta distribution is shown. d Genome browser view of the region highlighted in purple in a and b that contains the 3′ DGKB eQTL and T2D GWAS signals. Two regulatory elements (element 1 highlighted in green, element 2 highlighted in blue) overlapping ATAC-seq peaks in islet β-cells (islet single nuclei ATAC-seq49) and bulk islets (islet track represents one islet sample from Varshney et al.15) were cloned into a luciferase reporter assay construct for functional validation. All ATAC-seq tracks are normalized to 10 M reads and scaled from 0–15. e Log 2 luciferase assay activities (normalized to empty vector) are shown for in rat (832/13), mouse (MIN6), and human (EndoC-βH1) β-cell lines for the element 2 (cloned in the forward orientation), highlighted in blue in d. The risk haplotype shows significantly higher (p < 0.05) activity than the non-risk haplotype in 832/13 and MIN6, consistent with the eQTL direction shown in c. P-values were determined using unpaired two-sided t-tests. f EMSA for probes with risk and non-risk alleles at the four SNPs overlapping the regulatory element validated in e, using nuclear extract from MIN6 cells. Filled arrows, allele-specific binding; open arrows, non-allele-specific binding of proteins to probes. Source data are provided as a Source data file.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 98 references

Cited by

See all 166

Metadata

Authors
Viñuela, A., Varshney, A., van de Bunt, M., Prasad, R. B., Asplund, O., Bennett, A., Boehnke, M., Brown, A. A., Erdos, M. R., Fadista, J., Hansson, O., Hatem, G., Howald, C., Iyengar, A. K., Johnson, P., Krus, U., MacDonald, P. E., Mahajan, A., Manning Fox, J. E., Narisu, N., Nylander, V., Orchard, P., Oskolkov, N., Panousis, N. I., Payne, A., Stitzel, M. L., Vadlamudi, S., Welch, R., Collins, F. S., Mohlke, K. L., Gloyn, A. L., Scott, L. J., Dermitzakis, E. T., Groop, L., Parker, S. C. J., & McCarthy, M. I.
Affiliations
  • University of Geneva (CH)
  • University of Michigan (US)
  • Lund University (SE)
  • Centre for Human Genetics (GB)
  • National Institutes of Health (US)
  • Statens Serum Institut (DK)
  • University of Helsinki (FI)
  • University of North Carolina at Chapel Hill (US)
  • University of Alberta (CA)
  • University of Oxford (GB)
  • University of Connecticut (US)
Corresponding author
  • Viñuela, Ana
  • McCarthy, Mark I.
Venue
Nature Communications
Published
2020-09-30
Volume
11
Issue
1
Pages
4912-4912
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3091552000
Cited by
152
References
99
Citations by year
2026: 10 · 2025: 28 · 2024: 19 · 2023: 28 · 2022: 25 · 2021: 26 · 2020: 9
FWCI
13.49
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion, cc-by)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion, cc-by)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
  • UNC Libraries
  • Zenodo (CERN European Organization for Nuclear Research) (cc-by)
Funders
  • American Diabetes Association
  • AstraZeneca (2015-2558, 349-2006-237, 2009-1039)
  • University of Michigan
  • Åke Wiberg Stiftelse
  • Wellcome Trust (212259, 098381, 095101, 090532, 203141, 200837, 106130, 200837/Z/16/Z)
  • National Institute for Health and Care Research (NF-SI-0617-10090)
  • University of Oxford
  • European Commission (115317, HORIZON2020, 095101, 203141, 098381, 200837)
  • European Foundation for the Study of Diabetes (115317)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (149984, 148451)
  • Stiftelsen för Strategisk Forskning (Dnr 349-2006-237, 2009-1039, 349-2006-237, Dnr 2009-1039, Dnr IRC15‐0067, IRC15-0067)
  • Novo Nordisk
  • Vetenskapsrådet (349-2006-237, 2015-02558, 2006–237, 2009-1039, IRC15-0067, strategic Research Area Exodiab dnr 2009-1039, Dnr 349-2006-237, Dnr2009‐1039, Dnr IRC15-0067)
  • Alberta Diabetes Foundation
  • National Institutes of Health (NF-SI-0617-10090, 095101, NIH-R01, HG00040, ZIA-HG000024, HG000024)
  • Canadian Institutes of Health Research (CIHR: 148451, 14845_1)
  • Medical Research Council (/L020149/1, MR/L020149/1, L020149)
  • National Institute of Mental Health (R01MH101814, R01MH090941)
  • National Human Genome Research Institute (Z01HG000024, HG00040, T32 HG-00040, HG000024, T32HG000040, ZIAHG000024)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-072193, R01DK072193, R00DK099240, R00DK092251, U01DK062370, DK085545, 106130, 212259, R0-1-DK, 090532, U01DK085545, DK105561, NF-SI-0617-10090, U01DK105561, U01DK105535, U01-DK105535; U01-DK085545, K99DK092251, NIH R01, 098381, R01DK117960, 203141, P30DK020572, R01DK062370)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
type 2 diabetes, pancreatic islets, cis-eQTL, gene expression regulation, regulatory elements, TCF7L2, glycemic traits, colocalization, non-coding variants, tissue-specific gene expression
MeSH terms
RNA-Seq, Adolescent, Adult, Aged, Aged, 80 and over, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Enhancer Elements, Genetic, Female, Gene Expression Regulation, Humans, Islets of Langerhans, Male, Middle Aged, Cohort Studies, Sequence Analysis, DNA, Diacylglycerol Kinase, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Quantitative Trait Loci, Cell Line, Tumor, Mice, Genome-Wide Association Study, Young Adult, Transcription Factor 7-Like 2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D. https://app.cochat.ai/papers/10.1038/s41467-020-18581-8
The paper
Viñuela, A., Varshney, A., van de Bunt, M., Prasad, R. B., Asplund, O., Bennett, A., Boehnke, M., Brown, A. A., Erdos, M. R., Fadista, J., Hansson, O., Hatem, G., Howald, C., Iyengar, A. K., Johnson, P., Krus, U., MacDonald, P. E., Mahajan, A., Manning Fox, J. E., . . . McCarthy, M. I. (2020). Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D. Nature Communications. https://doi.org/10.1038/s41467-020-18581-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.